全文获取类型
收费全文 | 2810篇 |
免费 | 397篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 62篇 |
妇产科学 | 42篇 |
基础医学 | 336篇 |
口腔科学 | 53篇 |
临床医学 | 332篇 |
内科学 | 644篇 |
皮肤病学 | 58篇 |
神经病学 | 262篇 |
特种医学 | 210篇 |
外科学 | 392篇 |
综合类 | 75篇 |
一般理论 | 4篇 |
预防医学 | 306篇 |
眼科学 | 47篇 |
药学 | 229篇 |
肿瘤学 | 178篇 |
出版年
2023年 | 17篇 |
2021年 | 45篇 |
2020年 | 33篇 |
2019年 | 34篇 |
2018年 | 47篇 |
2017年 | 30篇 |
2016年 | 40篇 |
2015年 | 26篇 |
2014年 | 54篇 |
2013年 | 97篇 |
2012年 | 105篇 |
2011年 | 120篇 |
2010年 | 96篇 |
2009年 | 88篇 |
2008年 | 97篇 |
2007年 | 97篇 |
2006年 | 96篇 |
2005年 | 114篇 |
2004年 | 101篇 |
2003年 | 88篇 |
2002年 | 87篇 |
2001年 | 76篇 |
2000年 | 102篇 |
1999年 | 80篇 |
1998年 | 75篇 |
1997年 | 66篇 |
1996年 | 60篇 |
1995年 | 65篇 |
1994年 | 49篇 |
1993年 | 50篇 |
1992年 | 78篇 |
1991年 | 49篇 |
1990年 | 58篇 |
1989年 | 61篇 |
1988年 | 76篇 |
1987年 | 58篇 |
1986年 | 48篇 |
1985年 | 74篇 |
1984年 | 42篇 |
1983年 | 48篇 |
1982年 | 39篇 |
1981年 | 36篇 |
1980年 | 29篇 |
1979年 | 31篇 |
1978年 | 30篇 |
1977年 | 44篇 |
1976年 | 28篇 |
1975年 | 29篇 |
1971年 | 23篇 |
1970年 | 26篇 |
排序方式: 共有3238条查询结果,搜索用时 15 毫秒
71.
72.
73.
What constitutes a true hyperdense middle cerebral artery sign? 总被引:3,自引:0,他引:3
OBJECTIVES: The 'hyperdense MCA sign' refers to an appearance of increased attenuation of the proximal middle cerebral artery (MCA) that is often associated with thrombosis of the M1 MCA segment and may be the only diagnostic feature on computed tomography early after ischaemic stroke. False positives are recognized, and correct recognition of this sign has, therefore, assumed greater importance with the advent of thrombolytic therapy for stroke. We sought to define objective criteria for hyperdensity of the MCA. METHODS: Brain computed tomographs obtained by a standard protocol in a neuroradiology department were analyzed by a single observer. All consecutive scans reported as exhibiting a hyperdense MCA were compared to controls reported as having normal scans. Ovoid regions of interest were placed over the vessels and cerebral cortices, and the attenuation in Hounsfield units (HU) measured. Absolute attenuation and ratios of one side to the other were compared. RESULTS: MCA attenuation was unrelated to age in cases (n = 18) and controls (n = 80). The mean MCA attenuation was greater in the affected MCA of cases as compared with controls [54.0 HU (99% confidence interval CI 46.7-61.2) vs. 41.3 HU (99% CI 39.7-43.0); p < 0.00001]. Cases were subdivided into true and false positives by the ratio of denser:less dense MCA (within or without the 95% prediction interval for controls). In all true positives, the MCA ratio was > 1.2. 9 of 10 true positives had acute ischaemic stroke; 1 patient had herpes simplex encephalitis, but had MCA attenuation within the 95% CI for controls. False positives had mature cerebral infarction or non-ischaemic pathologies. The ratio of MCA attenuation to adjacent cerebral cortex was significantly higher in both true and false positives than in controls. CONCLUSIONS: Hyperdense MCAs associated with acute ischaemic stroke can be distinguished from normal vessels and false positives by measurement of absolute attenuation of affected and normal vessels: an absolute density of >43 HU and a MCA ratio of >1.2 defined hyperdensity and excluded all other pathologies. Confirmation in other centres is required. 相似文献
74.
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. 总被引:15,自引:0,他引:15
Daphne W Bell Thomas J Lynch Sara M Haserlat Patricia L Harris Ross A Okimoto Brian W Brannigan Dennis C Sgroi Beth Muir Markus J Riemenschneider Renee Bailey Iacona Annetta D Krebs David H Johnson Giuseppe Giaccone Roy S Herbst Christian Manegold Masahiro Fukuoka Mark G Kris José Baselga Judith S Ochs Daniel A Haber 《Journal of clinical oncology》2005,23(31):8081-8092
PURPOSE: Most cases of non-small-cell lung cancer (NSCLC) with dramatic responses to gefitinib have specific activating mutations in the epidermal growth factor receptor (EGFR), but the predictive value of these mutations has not been defined in large clinical trials. The goal of this study was to determine the contribution of molecular alterations in EGFR to response and survival within the phase II (IDEAL) and phase III (INTACT) trials of gefitinib. PATIENTS AND METHODS: We analyzed the frequency of EGFR mutations in lung cancer specimens from both the IDEAL and INTACT trials and compared it with EGFR gene amplification, another genetic abnormality in NSCLC. RESULTS: EGFR mutations correlated with previously identified clinical features of gefitinib response, including adenocarcinoma histology, absence of smoking history, female sex, and Asian ethnicity. No such association was seen in patients whose tumors had EGFR amplification, suggesting that these molecular markers identify different biologic subsets of NSCLC. In the IDEAL trials, responses to gefitinib were seen in six of 13 tumors (46%) with an EGFR mutation, two of seven tumors (29%) with amplification, and five of 56 tumors (9%) with neither mutation nor amplification (P = .001 for either EGFR mutation or amplification v neither abnormality). Analysis of the INTACT trials did not show a statistically significant difference in response to gefitinib plus chemotherapy according to EGFR genotype. CONCLUSION: EGFR mutations and, to a lesser extent, amplification appear to identify distinct subsets of NSCLC with an increased response to gefitinib. The combination of gefitinib with chemotherapy does not improve survival in patients with these molecular markers. 相似文献
75.
76.
77.
78.
Krishna A Dani Celestine Santosh David Brennan Donald M Hadley Keith W Muir 《Journal of cerebral blood flow and metabolism》2012,32(12):2114-2117
Hyperoxia during T2*-weighted magnetic resonance imaging (oxygen challenge imaging (OCI)) causes T2*-weighted signal change that is dependent on cerebral blood volume (CBV) and oxygen extraction fraction (OEF). Crossed cerebellar diaschisis (CCD), where CBV is reduced but OEF is maintained, may be used to understand the relative contributions of OEF and CBV to OCI results. In subjects with large hemispheric strokes, OCI showed reduced signal change in the contralesional cerebellum (P=0.027, n=12). This was associated with reduced CBV in contralesional cerebellum (P=0.039, n=9). CCD may be a useful model to determine the relative contribution of CBV to signal change measured by OCI. 相似文献
79.
J. M. Castor R. K. Wood A. J. Muir S. M. Palmer R. A. Shimpi 《Neurogastroenterology and motility》2010,22(8):841-850
Background Lung transplantation has become an effective therapeutic option for selected patients with end stage lung disease. Long‐term survival is limited by chronic rejection manifest as bronchiolitis obliterans syndrome (BOS). The aspiration of gastric contents has been implicated as a causative or additive factor leading to BOS. Gastroesophageal reflux (GER) and altered foregut motility are common both before and after lung transplantation. Further, the normal defense mechanisms against reflux are impaired in the allograft. Recent studies using biomarkers of aspiration have added to previous association studies to provide a growing body of evidence supporting the link between rejection and GER. Further, the addition of high‐resolution manometry (HRM) and impedance technology to characterize bolus transit and the presence and extent of reflux regardless of pH might better identify at‐risk patients. Although additional prospective studies are needed, fundoplication appears useful in the prevention or treatment of post‐transplant BOS. Purpose This review will highlight the existing literature on the relationship of gastroesophageal reflux and altered motility to lung transplant rejection, particularly BOS. The article will conclude with a discussion of the evaluation and management of patients undergoing lung transplantation at our center. 相似文献
80.